Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Prestige Consumer Healthcare (PBH) Invested Capital (2016 - 2025)

Historic Invested Capital for Prestige Consumer Healthcare (PBH) over the last 17 years, with Q4 2025 value amounting to $2.9 billion.

  • Prestige Consumer Healthcare's Invested Capital rose 297.06% to $2.9 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $2.9 billion, marking a year-over-year increase of 297.06%. This contributed to the annual value of $2.8 billion for FY2025, which is 166.73% up from last year.
  • Latest data reveals that Prestige Consumer Healthcare reported Invested Capital of $2.9 billion as of Q4 2025, which was up 297.06% from $2.8 billion recorded in Q3 2025.
  • Prestige Consumer Healthcare's Invested Capital's 5-year high stood at $3.1 billion during Q4 2022, with a 5-year trough of $2.8 billion in Q2 2024.
  • Over the past 5 years, Prestige Consumer Healthcare's median Invested Capital value was $2.8 billion (recorded in 2021), while the average stood at $2.9 billion.
  • As far as peak fluctuations go, Prestige Consumer Healthcare's Invested Capital skyrocketed by 807.8% in 2021, and later crashed by 999.82% in 2023.
  • Prestige Consumer Healthcare's Invested Capital (Quarter) stood at $3.0 billion in 2021, then rose by 2.04% to $3.1 billion in 2022, then decreased by 10.0% to $2.8 billion in 2023, then decreased by 0.7% to $2.8 billion in 2024, then rose by 2.97% to $2.9 billion in 2025.
  • Its Invested Capital was $2.9 billion in Q4 2025, compared to $2.8 billion in Q3 2025 and $2.8 billion in Q2 2025.